Primary record
3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione; Ketanserin; Ketensin; R 41468; Suffrexal; Vulketan Gel
- 库存
- 6,980 克
- 纯度
- 98.5 %
- CAS
- 74050-98-9
化合物标识与属性
- CAS
- 74050-98-9
- PubChem CID
- 3822
- SMILES
- C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O
- Canonical SMILES
- O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
名称与同义词
- Ketanserin
- Ketanserine
- Ketanserin tartrate
- 74050-98-9
- Ketanserina
- Ketanserinum
- Ketaserin
- Serefrex
- ketensin
- Perketal
- Serepress
- Sufrexal
- Taseron
- Vulketan Gel
- suffrexal
- Kentanserin
- Perketan
- [3H]-Ketanserin
- [3H]ketanserin
- Ketanserine [INN-French]
- Ketanserinum [INN-Latin]
- Ketanserina [INN-Spanish]
- CHEMBL51
- Ketanserin (Standard)
- Ketanserin (USAN/INN)
- C22H22FN3O3
- Tocris-0908
- KETANSERIN [MI]
- DTXSID3023188
- Ketanserin [USAN:BAN:INN]
- AC1L1GSK
- KETANSERIN [INN]
- RefChem:389088
- Spectrum2_001713
- 97F9DE4CT4
- KETANSERIN [USAN]
- UNII-97F9DE4CT4
- FPCCSQOGAWCVBH-UHFFFAOYSA-N
- Ketanserin (Vulketan Gel)
- Ketanserin tartrate hydrate
- MFCD00083392
- Biomol-NT_000096
- D08VRO
- GTPL88
- Ketanserin [USAN:INN:BAN]
- R 41468;Vulketan Gel
- KETANSERIN [MART.]
- CHEBI:6123
- DTXCID103188
- KETANSERIN [WHO-DD]
- R-41468
- SCHEMBL34294
- 3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)ethyl)quinazoline-2,4(1H,3H)-dione
- GTPL197
- MLS006010073
- SPECTRUM1505346
- EINECS 277-680-2
- SPBio_001726
- BPBio1_001356
- orb1309882
- R-41,468
- R 41468
- CHEMBL1628637
- NSC-758959
- SCHEMBL29361038
- UNII-645498QK7H
- BDBM21395
- CTK8G0431
- KS-00000XLH
- AOB5639
- C02KD01
- CID3822
- KJK 945
- KJK-945
- GLXC-06518
- HMS1923O11
- HMS2090H18
- HMS2094I03
- HMS3655H14
- HMS3887G17
- HMS5087J17
- Pharmakon1600-01505346
- ZINC537877
- R 41,468
- C22H22FN3O3.C4H6O6
- CID:3822
- EINECS 281-062-8
- Tox21_110865
- C22-H22-F-N3-O3
- CCG-39512
- EBC-08725
- HY-10562R
- NCGC00021146-06
- NSC758959
- PDSP1_000639
- PDSP2_000634
- s2232
- 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione
- AKOS015895130
- Tox21_110865_1
- AC-2024
- AN-5822
- CS-6055
- DB12465
- FF24757
- GS-3601
- RL04800
- SDCCGSBI-0051158.P004
- R41468
- NCGC00021146-01
- NCGC00021146-02
- NCGC00021146-03
- NCGC00021146-04
- NCGC00021146-05
- NCGC00021146-07
- NCGC00021146-08
- NCGC00021146-09
- NCGC00021146-12
- NCGC00021146-22
- NCGC00024865-01
- NCGC00024865-02
- NCGC00024865-03
- NCGC00024865-04
- NCGC00024865-05
- AJ-23373
- BC202701
- HY-10562
- J12.099E
- K261
- R41,468
- SC-17248
- SID:53789966
- SMR001550601
- SY053064
- SBI-0051158.P003
- AB0014126
- AB2000544
- CAS-74050-98-9
- DB-055834
- LS-140148
- B2248
- FT-0630827
- FT-0653664
- K0051
- NS00001319
- R 49945
- SW196882-3
- C22-H22-F-N3-O3.C4-H6-O6
- 1H,1H,2H,2H-Perfluorodecylmethyldichlorosilane
- 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione
- 3-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2,4-(1H,3H)-quinazolinedione
- 3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione
- A10497
- C07464
- D02363
- 2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-
- 050K989
- 191037-EP2275420A1
- 191037-EP2280008A2
- A838000
- D007650
- L000764
- Q415997
- R-49945
- R41 468
- 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}quinazoline-2,4(1H,3H)-dione
- I06-0365
- R 41 468
- R-41-468
- BRD-K49671696-001-02-1
- BRD-K49671696-001-05-4
- BRD-K49671696-045-08-5
- BRD-K49671696-046-01-8
- BRD-K49671696-347-02-8
- 3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-ethyl)quinazoline-2,4(1H,3H)-dione
- 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione
- 83846-83-7
- F2173-1039
- Z2216887910
- 2,4(1H,3H)-Quinazolinedione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-
- 3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)-1,2,3,4-tetrahydroquinazoline-2,4-dione
- 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4[1H,3H]-quinazolinedione
- KETANSERIN, Ketanserin tartrate hydrate, KETANSERIN TARTRATE
- (+)-3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione
- 3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)quinazoline-2,4(1H,3H)-dione
- 3-[2-[4-(4-fluorophenyl)carbonylpiperidin-1-yl]ethyl]-1~{H}-quinazoline-2,4-dione
- 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1,2,3,4-tetrahydroquinazoline-2,4-dione
- 3-(2-(4-(4-fluorobenzoyl)piperidin-1-yl)ethyl)-1H-quinazoline-2,4-dione
- 3-[2-[4-(4-Fluorobenzoyl)piperidino]ethyl]-2,4(1H,3H)-quinazolinedione
- 3-[2-[4-(p-Fluorobenzoyl)piperidino]ethyl]-2,4-(1H,3H)-quinazolinedione
- 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1H-quinazoline-2,4-dione
- 2,4(1H,3H)-Quinazolinedione,3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-
- 2,4(1h,3h)quinazolinedione,3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-
- 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2,4(1H,3H)-quinazolinedione
- 3-(2-(4-(p-Fluorobenzoyl)-1-piperidinyl)ethyl)-2,4(1H,3H)-quinazolinedione L-tartrate
- 3-(2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl)-2,4(1H,3H)-quinazolinedione #
- 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]-ethyl]-2,4-[1H, 3H]-quinazolinedione
- 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4-(1H,3H)-quinazolinedione
- 3-[2-[4-(4-Fluorobenzoyl)-1-piperidyl]ethyl]quinazoline-2,4(1H,3H)-dione
- 3-[2-[4-(4-Fluorobenzoyl)piperidin-1-yl]ethyl]-2,4(1H,3H)-quinazolinedione
- 3-{2-[4-(4-fluoro-benzoyl)-piperidin-1-yl]-ethyl}-1h-quinazoline-2,4-dione
- 3-{2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl}-2,4(1H,3H)-quinazolinedione
- 277-680-2
- 3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione; Ketanserin; Ketensin; R 41468; Suffrexal; Vulketan Gel
- 3-[2-[4-(4-fluorobenzoyl)piperidino]ethyl]quinazoline-2,4(1H,3H)-dione [R-(R*,R*)]-tartrate
- UYX